Biovica Expands Japanese Patent Protection in Immuno-Oncology

Biovica, specializing in blood-based cancer monitoring, today announced that the Japanese Patent Office has issued a Notice of Allowance for a new patent application covering the use of TKa during ongoing treatment with immune checkpoint inhibitors …